April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Long-term results of laser photocoagulation sparing the papillomacular bundle for peripapillary polypoidal choroidal vasculopathy lesions
Author Affiliations & Notes
  • Yukari Shirakata
    Ophthalmology, Kagawa University Faculty of Medicine, Kita-gun, Japan
  • Fumio Shiraga
    Ophthalmology, Okayama University Faculty of Medicine, Okayama, Japan
  • Chieko Shiragami
    Ophthalmology, Kagawa University Faculty of Medicine, Kita-gun, Japan
  • Ayana Yamashita
    Ophthalmology, Kagawa University Faculty of Medicine, Kita-gun, Japan
  • Atsushi Fujiwara
    Ophthalmology, Okayama University Faculty of Medicine, Okayama, Japan
  • Footnotes
    Commercial Relationships Yukari Shirakata, None; Fumio Shiraga, Alcon Japan (C), Bausch & Lomb Japan (C), Byer (C), Novartis Pharma (C), Santen Pharma (C); Chieko Shiragami, None; Ayana Yamashita, None; Atsushi Fujiwara, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 6345. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yukari Shirakata, Fumio Shiraga, Chieko Shiragami, Ayana Yamashita, Atsushi Fujiwara; Long-term results of laser photocoagulation sparing the papillomacular bundle for peripapillary polypoidal choroidal vasculopathy lesions. Invest. Ophthalmol. Vis. Sci. 2014;55(13):6345.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the safety and effectiveness of laser photocoagulation for indocyanine green angiography (ICGA)-identified peripapillary polypoidal choroidal vasculopathy (PPCV) lesions.

Methods: Twenty-five consecutive PPCV eyes with serous retinal detachments in the macula, which were treated with direct laser photocoagulation, were retrospectively reviewed. No patient had undergone previous treatment for PCV. All 25 eyes were treated with multicolor red (659 nm) laser photocoagulation. The laser spot was focused on the retinal pigment epithelium underneath the detached retina to spare the papillomacular bundle. Laser photocoagulation targeted the entire ICGA-identified lesion, including both the polypoidal lesions and the branching vascular network.

Results: The mean follow-up period after the first treatment was 43.9 months (range, 12-113months). The logMAR BCVA was stable or improved by ≥0.3 logMAR in 22 eyes (88.0%). Six cases had recurrent leakage requiring retreatment. Three of 6 cases required photodymanic therapy, resulting in visual acuity loss by ≥0.3 logMAR. The other 3 cases administered some sessions of intravitreal anti-VEGF agents, resulting in visual acuity stability. Nineteen (76.0%) of the 25 studied eyes required no additional treatment during follow-up.

Conclusions: For PPCV, laser photocoagulation was effective in maintaining or improving visual acuity with only a single treatment session over a long period, because laser photocoagulation was administered for all vascular lesions, sparing the papillomacular bundle.

Keywords: 412 age-related macular degeneration • 578 laser • 453 choroid: neovascularization  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×